Price Differences and Buying Guide of Different Versions of Generic Drugs of Pralsetinib

In the Chinese market, the original drug of Platinib (Gavreto®) has been approved for marketing, but it has not yet been included in the national medical insurance system, which puts great pressure on patients to pay out-of-pocket. Common specifications on the market include “100 mg×60 capsules” and “100 " mg Although there is no official public unified price mechanism, actual clinical and patient feedback show that the cost of original drugs is extremely high, which poses a significant financial burden to patients undergoing long-term treatment.

The price of the original drug Platinib in overseas markets is even more expensive. According to some channels, the price of a box of 60 capsules fluctuates between 40,000 yuan and more than 100,000 yuan, depending on factors such as pricing policies, taxes and import duties in the country or region. This huge fluctuation in price range has made it prohibitive for many patients with average financial conditions. However, with the development of the global pharmaceutical industry, some countries and regions have developed generic drugs of Platinib, which are relatively cheap and provide patients with more choices.

Take the generic drug Platinib produced in Laos as an example. Its specification is 120 capsules and the price is about more than 3,000 yuan. Compared with the original drug, which often costs tens of thousands or even hundreds of thousands of yuan, this generic version has a significant cost advantage. Generic drugs usually use the same active ingredients as original drugs and have similar therapeutic effects in theory, but their prices can drop significantly due to factors such as production location, production costs and patent restrictions. This means that for patients who cannot afford the cost of original drugs due to financial reasons, generic drugs provide a pragmatic and feasible alternative.

Faced with original drugs and generic drugs with huge price differences, patients need to weigh carefully when making a choice. First of all, it is recommended to give priority to consulting medication information through formal medical channels (such as tertiary hospitals or certified pharmacies) to ensure that the source of purchased drugs is legal and the quality is controllable. Secondly, pay attention to the country of origin of the drug, manufacturer qualifications and drug registration status, and avoid purchasing products from unknown sources. For patients with financial difficulties, they can inquire whether the hospital or related charity projects provide assistance or subsidies. Finally, if you choose generic drugs, you must keep monitoring the treatment process, regularly evaluate efficacy and safety, and maintain communication with the attending doctor to ensure that the treatment continues to be effective.

Reference link:https://www.drugs.com